TTRX logo

Turn Therapeutics Inc.

TTRX
Healthcare|Biotechnology|US
$9.48
+0.54 (+6.04%)
DCF Value
$0.18
Cash / Share
$0.35

About

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Stock Price

+123.1%(1Y)
1M
-16.8%
3M
-8.9%
6M
+150.1%
YTD
+140.6%
1Y
+129.5%
3Y
+35.4%
5Y
+35.4%

Pipeline Summary

3 total trials
0
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
Recruiting: 2Completed: 1

Active Trials (2)

Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
NCT06672887Cancer
Phase 2Phase 3Recruiting
Enrollment: 140 participants
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
NCT07355075Eczema Atopic Dermatitis
Phase 2Phase 3Recruiting
Enrollment: 190 participants

Key Facts

Market Cap$287.9M
Employees2
CEOBradley E. Burnam
IPO DateOct 8, 2025
Beta2.04
52-Week Range$2.57 – $16.45
Avg Volume112,760
ExchangeNASDAQ

Ownership

Float36.4%
Shares Outstanding30.4M

Peers

AGENAgenus Inc.
$322.9M
ANIXAnixa Biosciences, Inc.
$110.4M
CGTXCognition Therapeutics, Inc.
$65.3M
GLSIGreenwich LifeSciences, Inc.
$222.7M
HURATuHURA Biosciences, Inc.
$103.9M
IKTInhibikase Therapeutics, Inc.
$209.3M
IRDOpus Genetics, Inc.
$347.8M
SEERSeer, Inc.
$90.3M
Data last updated: Nov 9, 2026, 04:38 AM